ASX:COHMedical Equipment
Cochlear (ASX:COH) Valuation After Profit Drop Nexa Delays And Lowered Outlook
Cochlear (ASX:COH) is back in focus after its half year result showed net income of A$161.5 million and a lower full year profit outlook, alongside contracting delays for the new Nucleus Nexa system.
See our latest analysis for Cochlear.
The sharp post earnings selloff has left Cochlear at a share price of A$199.81, with a 7 day share price return of 22.22% and a 1 year total shareholder return of 25.96%. This signals fading momentum as investors reassess risks around Nexa adoption and the...